Clinical Research Directory
Browse clinical research sites, groups, and studies.
Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies
Sponsor: M.D. Anderson Cancer Center
Summary
This study collects information on outcomes after chimeric antigen receptor therapy and radiation therapy for hematologic malignancies. Collecting information from patients before, during, and after receiving chimeric antigen receptor therapy or radiation therapy may help doctors to optimize patient selection, dose, timing, and sequencing of these treatments.
Official title: Outcomes After Chimeric Antigen Receptor Therapy (CAR-T) and Radiation Therapy (RT) for Hematologic Malignancies
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2021-04-10
Completion Date
2026-11-14
Last Updated
2025-10-27
Healthy Volunteers
No
Conditions
Interventions
Data Capture
Treatment related data is collected
Electronic Medical Record
Medical records are reviewed
Locations (1)
M D Anderson Cancer Center
Houston, Texas, United States